Results 291 to 300 of about 83,408 (314)

MBOAT7 encephalopathy: Characterizing the neurology and epileptology

open access: yesEpilepsia, EarlyView.
Abstract Objective Biallelic pathogenic MBOAT7 variants are associated with neurodevelopmental disorders, intellectual disability (ID), epilepsy, and neuropsychiatric disorders such as attention‐deficit/hyperactivity disorder and autism spectrum disorders. We aimed to characterize the epilepsy phenotype in a cohort of patients affected by this syndrome.
Sebastian Ortiz De la Rosa   +28 more
wiley   +1 more source

Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real‐world study

open access: yesEpilepsia, EarlyView.
Abstract Objective This real‐world, retrospective, multicenter study aims to investigate the effectiveness of highly purified cannabidiol (CBD) in a large cohort of patients with epilepsy of genetic etiology due to an identified monogenic cause. Additionally, we examine the potential relationship between specific genetic subgroups and treatment ...
Emanuele Cerulli Irelli   +68 more
wiley   +1 more source

Tailoring antiseizure treatment with a wearable device: A proof‐of‐concept study in absence epilepsy

open access: yesEpilepsia, EarlyView.
Abstract Objective Typical absence seizures are underreported. We aimed to improve patient care using a wearable electroencephalograph (wEEG) at home and assess a machine learning (ML) pipeline for absence detection. Methods Patients with typical absences used a wEEG device 12–24 h 1 week after antiseizure medication (ASM) adjustments.
Jaiver Macea   +4 more
wiley   +1 more source

Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy. [PDF]

open access: yesFront Pain Res (Lausanne)
Wong ML   +8 more
europepmc   +1 more source

Deep brain stimulation of the centromedian nucleus for drug‐resistant epilepsy in children: Quality‐of‐life and functional outcomes from the CHILD‐DBS registry

open access: yesEpilepsia, EarlyView.
Abstract Objective Deep brain stimulation of the centromedian nucleus of the thalamus (CM‐DBS) is an investigational, off‐label treatment for drug‐resistant epilepsy (DRE) in children. Although emerging evidence supports its safety and efficacy for select indications, the effect of CM‐DBS on quality of life and functional outcomes such as school ...
Karim Mithani   +21 more
wiley   +1 more source

Vagus nerve stimulation (VNS): recent advances and future directions. [PDF]

open access: yesClin Auton Res
Austelle CW   +3 more
europepmc   +1 more source

Developmental and epileptic encephalopathy in patients with epilepsy due to hypothalamic hamartomas

open access: yesEpilepsia, EarlyView.
Abstract Objective What factors influence cognition and behavior in patients with epilepsy caused by hypothalamic hamartoma (HH)? Methods We conducted a retrospective study of 103 patients referred to the Epilepsy Center in Freiburg, Germany, over the past 24 years.
Kathrin Wagner   +9 more
wiley   +1 more source

Status Epilepticus Treated With Vagus Nerve Stimulation in an Adult With Cortical Dysplasia: A Case Report. [PDF]

open access: yesCureus
Gómez-Oropeza I   +7 more
europepmc   +1 more source

Frequency‐specific alterations in brain connectivity induced by pulvinar stimulation

open access: yesEpilepsia, EarlyView.
Abstract Objective Deep brain stimulation (DBS) is emerging as a promising therapy for patients with drug‐resistant epilepsy, particularly those who are either unsuitable for or unresponsive to resective surgery. The potential benefit of DBS in these patients may stem from its ability to reduce excessive brain functional connectivity (FC).
Emma Acerbo   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy